• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal & Metabolism
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality
      • Environment, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Molecular glues bring proteins together
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Discovery

Visualizing molecular glues

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

By
Elizabeth Dougherty
Mar 27, 2020

Every cell in the human body is packed with proteins. These large molecules float around, bump into one another and make the stuff of life happen. They turn fuel into energy. They dispose of trash. They read genetic codes and coax cells to divide.

In some cells, naturally occurring “molecular glues” float among these proteins. Like crafty matchmakers, these small molecules stick proteins together. By doing so, they may change a cell’s destiny.

Drug hunters at the Novartis Institutes for BioMedical Research (NIBR) think these tiny matchmakers also have the potential to change the course of disease. Our researchers are taking a systematic approach to discovering molecular glues in an effort to alter disease-driving biology. Glues work differently from traditional small-molecule drugs, so they could help us find new ways to treat tough diseases such as cancer.

“They really represent a new type of medicine,” says Jonathan Solomon, a biologist at Novartis who is working to discover disease-disrupting molecular glues.

Nature’s matchmakers

arabidopsis thaliana.
Molecular glues were discovered in plants. Here, arabidopsis thaliana seen under confocal laser scanning microscopy. Image credit: Heiti Paves.

Nature created molecular glues. They were first discovered in plants such as arabidopsis thaliana, shown here under a microscope. Some small-molecule hormones in plants work by sticking proteins together. Some antibiotics that plants produce to defend themselves also work by sticking proteins together.

“We actually feel that this is something in nature that is exploited a lot,” says Rohan Beckwith, a chemist at Novartis who is also driving molecular glue discovery efforts. “Yet the idea of a small molecule bringing two proteins together to impact disease biology has been largely unexplored in drug discovery.”

How glues work

Molecular glues bring proteins together.
Molecular glues bring proteins together. Animation by Mark Mazaitis, modified by Fidelis Onwubueke.

In a cell, proteins are constantly bumping into one another. Many cellular activities happen as a result of protein-protein interactions. Molecular glues perform their matchmaking by sticking a protein to itself or to another protein.

The power of molecular glues in medicine is that they can stick proteins together that don’t normally interact. Since protein-protein interactions drive most biological activities, molecular glues open the door to driving biology that fights disease.

For instance, we can potentially use glues to coax a cell to dispose of a disease-driving protein by sticking a “trash” tag to it. We might also stick a disease-related protein to itself so that it no longer functions, thereby shutting down a disease-related process.

A new type of medicine

We need new medicines because there are still many diseases that we can’t treat with conventional small-molecule therapeutics. The prevailing approach in recent history has been to use small molecules to break apart protein-protein interactions. This approach has been effective, but researchers have learned that it only works with proteins that have special features.

It turns out that many proteins involved in disease don’t have these special features. Molecular glues, with their protein-pairing capabilities, provide an alternative: bringing proteins together and making new protein-protein interactions to interrupt disease biology.

Molecular glue kills cancer cells in mice
From Our Labs

Molecular glue kills cancer cells in mice

Image and animation by Mark Mazaitis.

Shareline

Novartis researchers are working to discover disease-disrupting molecular glues. #drugdiscovery
Tweet Tweetpopo

Reimagine medicine with Novartis

The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.

Learn more

Tags: 
Drug Discovery, Innovation, Novartis Institutes for BioMedical Research, Scientific Research

Elizabeth Dougherty

Elizabeth Dougherty

is a science writer at the Novartis Institutes for BioMedical Research.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

A kidney patient is smiling at the camera
Discovery

New hope for treating inflammatory diseases of the kidney

2D rendering of kidneys
Discovery

Predictive analytics could bring medicines to patients faster

Discovery

Making Possible: Stepping toward a future with cell and gene therapy

You are here

  1. Home ›
  2. Stories ›
  3. Discovery

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.